MedPath

Fibre, protein and insulin resistance diet study

Phase 1
Completed
Conditions
Insulin resistance in healthy overweight women.
Diabetes prevention in healthy overweight women.
Metabolic syndrome in healthy overweight women.
Metabolic and Endocrine - Diabetes
Diet and Nutrition - Obesity
Registration Number
ACTRN12607000154404
Lead Sponsor
Dr Kirsten McAuley
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Female
Target Recruitment
72
Inclusion Criteria

Overweight; BMI = 27 kg/m2 and weight < 120 kg or BMI >23 kg/m2 and a direct family history of type 2 diabetes.Normal or impaired glucose tolerance.Weight stable over last 3 months and willing to maintain weight initially.Prepared to undergo dietary intervention and eat substantial amounts of dietary fibre including wholegrains, legumes and pulses.

Exclusion Criteria

No diabetes, history of cardiovascular disease, or renal or hepatic failure.Not suffering from any other major medical condition.No psychiatric illness, drug or alcohol dependence that would affect ability to adhere to the dietary guidelines.Not pregnant or lactating.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Insulin resistance measured by both a new dynamic method and Homeostasis Model Assessment for Insulin Resistance (HOMA-IR)[At baseline, 4 weeks and 10 weeks.]
Secondary Outcome Measures
NameTimeMethod
Weight[At baseline, 4 weeks and 10 weeks.];Fasting plasma lipids, glucose, insulin, C-Reactive protein (CRP), plasminogen activator inhibitor-1 (PAI-1), adiponectin, interleukin 6 (IL6), interleukin 18 (IL18), tumour necrosis factor alpha and grehlin; and percentage body fat mass and lean mass, and waist and hip circumference.[At baseline and 10 weeks]
© Copyright 2025. All Rights Reserved by MedPath